Diffuse large B-cell lymphoma arising from donor lymphoid cells after renal and pancreatic transplantation

[1]  I. Penn.  Cancers in renal transplant recipients. , 2000, Advances in renal replacement therapy.

[2]  J. Sastre,et al.  High Grade Lymphoma in a Post-Renal Transplant Patient , 2000, Nephron.

[3]  L. Swinnen,et al.  Diagnosis and treatment of transplant-related lymphoma. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  V. Leblond,et al.  Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  M. Callaghan,et al.  Rituximab: a new monoclonal antibody therapy for non-Hodgkin's lymphoma. , 2000, Oncology nursing forum.

[6]  Pfeffer Pf.  Cancer in organ transplanted patients , 1999 .

[7]  C. White,et al.  Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma. , 1999, Seminars in oncology.

[8]  C. White.  Rituximab immunotherapy for non-Hodgkin's lymphoma. , 1999, Cancer biotherapy & radiopharmaceuticals.

[9]  R. Schilder.  Rituximab immunotherapy. , 1999, Cancer biotherapy & radiopharmaceuticals.

[10]  P. Pfeffer.  [Cancer in organ transplanted patients]. , 1999, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[11]  A. Fischer,et al.  Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome. , 1998, Blood.

[12]  E. Cesarman,et al.  BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome. , 1998, Blood.

[13]  S. Swerdlow.  Classification of the posttransplant lymphoproliferative disorders: from the past to the present. , 1997, Seminars in diagnostic pathology.

[14]  E. Cesarman,et al.  Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin. , 1995, The American journal of pathology.

[15]  Emili Montserrat,et al.  A predictive model for aggressive non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.

[16]  L. Mcbride,et al.  Application of automated DNA sizing technology for genotyping microsatellite loci. , 1992, Genomics.

[17]  B. Griffith,et al.  Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. , 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  M. Zutter,et al.  Epstein-Barr virus lymphoproliferation after bone marrow transplantation. , 1988, Blood.

[19]  B. Burke,et al.  Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. , 1988, Blood.